データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
米国ETF銘柄情報
HELX Franklin Genomic Advancements Etf
- 29.790
- +0.422+1.44%
終値 12/24 13:00 ET
29.790高値29.310安値
29.790高値29.310安値4,009株出来高29.310始値29.368前日終値11.89万売買代金0.89%売買回転率--前年PER45.00万株式総数33.97652週高--PBR1,340.51万浮動時価28.30052週安--直近配当45.00万浮動株数58.462上場高--配当利回1.63%振幅18.344上場安29.646平均価格1株売買単元
日中
- 5日
- 日足
- 週足
- 月足
- Q足
- 年足
注文・約定分析
単位: --
積極売買トレンド
日中日週月
データなし
ニュース
Eli Lilly's Weight Loss Med Tirzepatide Gets Endorsement From U.K.'s NICE
Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years
Ely Lilly Shares Are Trading Higher After the FDA Approved the Company's Zepbound, a Weight Loss Drug Designed to Treat Moderate-to-severe Obstructive Sleep Apnea in Adults With Obesity.
Eli Lilly Stock Is Rising Monday: What's Going On?
14 Analysts Have This To Say About Danaher
Vertex Pharmaceuticals: Alyftrek Is An 'Accretive Opportunity' On Top- And Bottom-Lines, Says Bullish Analyst